
TCG CROSSOVER MANAGEMENT, LLC
Latest 13F filing data - Q3 2025
Holdings (Top positions)
| Stock | Ticker | ||
|---|---|---|---|
![]() | DNTH | 1.68M | $65.98M |
![]() | ADVM | 1.67M | $7.56M |
![]() | RAPT | 1.64M | $42.20M |
![]() | ARVN | 1.62M | $13.78M |
![]() | AGIO | 1.43M | $57.40M |
![]() | ADCT | 1.39M | $5.56M |
![]() | TRML | 1.31M | $62.74M |
![]() | PEPG | 1.20M | $5.54M |
![]() | KOD | 1.15M | $18.75M |
![]() | SYRE | 1.10M | $18.45M |
![]() | GPCR | 1.06M | $29.76M |
![]() | URGN | 717K | $14.31M |
![]() | MBX | 650K | $11.38M |
![]() | TRDA | 585K | $3.39M |
![]() | AVTX | 483K | $6.14M |
![]() | IRON | 465K | $30.74M |
![]() | RVMD | 436K | $20.38M |
![]() | KRRO | 416K | $19.94M |
![]() | VTYX | 316K | $983.37K |
![]() | MNPR | 153K | $12.50M |

Dianthus Therapeutics, Inc.
DNTH
Shares Held
1.68M
Value
$65.98M

Adverum Biotechnologies, Inc.
ADVM
Shares Held
1.67M
Value
$7.56M

RAPT Therapeutics, Inc.
RAPT
Shares Held
1.64M
Value
$42.20M

Arvinas, Inc.
ARVN
Shares Held
1.62M
Value
$13.78M

Agios Pharmaceuticals, Inc.
AGIO
Shares Held
1.43M
Value
$57.40M

ADC Therapeutics S.A.
ADCT
Shares Held
1.39M
Value
$5.56M

Tourmaline Bio, Inc.
TRML
Shares Held
1.31M
Value
$62.74M

PepGen Inc.
PEPG
Shares Held
1.20M
Value
$5.54M

Kodiak Sciences Inc.
KOD
Shares Held
1.15M
Value
$18.75M

Spyre Therapeutics, Inc.
SYRE
Shares Held
1.10M
Value
$18.45M

Structure Therapeutics Inc.
GPCR
Shares Held
1.06M
Value
$29.76M

UroGen Pharma Ltd.
URGN
Shares Held
717K
Value
$14.31M

MBX Biosciences, Inc. Common Stock
MBX
Shares Held
650K
Value
$11.38M

Entrada Therapeutics, Inc.
TRDA
Shares Held
585K
Value
$3.39M

Avalo Therapeutics, Inc.
AVTX
Shares Held
483K
Value
$6.14M

Disc Medicine, Inc.
IRON
Shares Held
465K
Value
$30.74M

Revolution Medicines, Inc.
RVMD
Shares Held
436K
Value
$20.38M

Korro Bio, Inc.
KRRO
Shares Held
416K
Value
$19.94M

Ventyx Biosciences, Inc.
VTYX
Shares Held
316K
Value
$983.37K

Monopar Therapeutics Inc.
MNPR
Shares Held
153K
Value
$12.50M
